In particular, the noteworthy similarity between CCS and MM delineated here may pave the way for the identification of new differentiation therapies that render both tumors, as well as other EWSR1-ATF1-associated diseases, more sensitive to available therapies. This evidence concerns the gene ATF1 and Miyoshi myopathy.